Thomas Lategan
General Counsel bei BRIGHT MINDS BIOSCIENCES INC.
Aktive Positionen von Thomas Lategan
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| BRIGHT MINDS BIOSCIENCES INC. | General Counsel | 14.06.2021 | - |
Karriereverlauf von Thomas Lategan
Ehemalige bekannte Positionen von Thomas Lategan
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
NeurAxon, Inc.
 NeurAxon, Inc. Miscellaneous Commercial ServicesCommercial Services NeurAxon, Inc. is engaged in the research and development of growing and unmet needs for chronic pain management. It is focused on developing pain therapeutics targeting neuronal Nitric Oxide Synthase (nNOS) inhibitors. The companyw as founded in 2004 and is headquartered in Mississauga, ON. | General Counsel | 01.09.2008 | 01.11.2015 |
| PANACOS PHARMACEUTICALS, INC. | General Counsel | 01.02.2007 | 01.09.2008 |
Actelion Pharmaceuticals US, Inc.
 Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a company that manufactures, distributes and markets drugs. The company is based in Titusville, NJ. The CEO of the company is Samuele Butera. | General Counsel | 01.02.2000 | 01.02.2007 |
| THE MEDICINES COMPANY | General Counsel | 01.03.1997 | 01.02.2000 |
| Roche Corp. | Corporate Officer/Principal | - | - |
Ausbildung von Thomas Lategan
| University of Oxford | Doctorate Degree |
| University of Aberdeen | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 6 |
| Vereinigtes Königreich | 3 |
| Kanada | 2 |
Operativ
| General Counsel | 5 |
| Doctorate Degree | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| PANACOS PHARMACEUTICALS, INC. | Health Technology |
| BRIGHT MINDS BIOSCIENCES INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Actelion Pharmaceuticals US, Inc.
Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a company that manufactures, distributes and markets drugs. The company is based in Titusville, NJ. The CEO of the company is Samuele Butera. | Health Technology |
The Medicines Co.
 The Medicines Co. Pharmaceuticals: MajorHealth Technology The Medicines Co. is a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on acute and intensive care hospitals worldwide. The firm markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ. | Health Technology |
NeurAxon, Inc.
NeurAxon, Inc. Miscellaneous Commercial ServicesCommercial Services NeurAxon, Inc. is engaged in the research and development of growing and unmet needs for chronic pain management. It is focused on developing pain therapeutics targeting neuronal Nitric Oxide Synthase (nNOS) inhibitors. The companyw as founded in 2004 and is headquartered in Mississauga, ON. | Commercial Services |
| Roche Corp. |
- Börse
- Insiders
- Thomas Lategan
- Erfahrung
